150 related articles for article (PubMed ID: 37269844)
1. Global funding for cancer research between 2016 and 2020: a content analysis of public and philanthropic investments.
McIntosh SA; Alam F; Adams L; Boon IS; Callaghan J; Conti I; Copson E; Carson V; Davidson M; Fitzgerald H; Gautam A; Jones CM; Kargbo S; Lakshmipathy G; Maguire H; McFerran K; Mirandari A; Moore N; Moore R; Murray A; Newman L; Robinson SD; Segaran A; Soong CN; Walker A; Wijayaweera K; Atun R; Cutress RI; Head MG
Lancet Oncol; 2023 Jun; 24(6):636-645. PubMed ID: 37269844
[TBL] [Abstract][Full Text] [Related]
2. The allocation of USdollar;105 billion in global funding from G20 countries for infectious disease research between 2000 and 2017: a content analysis of investments.
Head MG; Brown RJ; Newell ML; Scott JAG; Batchelor J; Atun R
Lancet Glob Health; 2020 Oct; 8(10):e1295-e1304. PubMed ID: 32971052
[TBL] [Abstract][Full Text] [Related]
3. Global public and philanthropic investment in childhood cancer research: systematic analysis of research funding, 2008-16.
Loucaides EM; Fitchett EJA; Sullivan R; Atun R
Lancet Oncol; 2019 Dec; 20(12):e672-e684. PubMed ID: 31797794
[TBL] [Abstract][Full Text] [Related]
4. Research investments for UK infectious disease research 1997-2013: A systematic analysis of awards to UK institutions alongside national burden of disease.
Head MG; Brown RJ; Clarke SC
J Infect; 2018 Jan; 76(1):11-19. PubMed ID: 29061335
[TBL] [Abstract][Full Text] [Related]
5. Investments in cancer research awarded to UK institutions and the global burden of cancer 2000-2013: a systematic analysis.
Maruthappu M; Head MG; Zhou CD; Gilbert BJ; El-Harasis MA; Raine R; Fitchett JR; Atun R
BMJ Open; 2017 Apr; 7(4):e013936. PubMed ID: 28428185
[TBL] [Abstract][Full Text] [Related]
6. Global funding trends for malaria research in sub-Saharan Africa: a systematic analysis.
Head MG; Goss S; Gelister Y; Alegana V; Brown RJ; Clarke SC; Fitchett JRA; Atun R; Scott JAG; Newell ML; Padmadas SS; Tatem AJ
Lancet Glob Health; 2017 Aug; 5(8):e772-e781. PubMed ID: 28668230
[TBL] [Abstract][Full Text] [Related]
7. Global trends in psycho-oncology research investments 2016-2020: A content analysis.
Conti I; Davidson M; Cutress RI; McIntosh SA; Head MG
Psychooncology; 2024 Jan; 33(1):e6273. PubMed ID: 38141045
[TBL] [Abstract][Full Text] [Related]
8. Research Investments in Global Health: A Systematic Analysis of UK Infectious Disease Research Funding and Global Health Metrics, 1997-2013.
Head MG; Fitchett JR; Nageshwaran V; Kumari N; Hayward A; Atun R
EBioMedicine; 2016 Jan; 3():180-190. PubMed ID: 26870829
[TBL] [Abstract][Full Text] [Related]
9. Allocation of funding into blast injury-related research and blast traumatic brain injury between 2000 and 2019: analysis of global investments from public and philanthropic funders.
Denny JW; Brown RJ; Head MG; Batchelor J; Dickinson AS
BMJ Mil Health; 2023 Apr; 169(2):127-132. PubMed ID: 33243763
[TBL] [Abstract][Full Text] [Related]
10. Funding infectious disease research: a systematic analysis of UK research investments by funders 1997-2010.
Fitchett JR; Head MG; Cooke MK; Wurie FB; Atun R
PLoS One; 2014; 9(8):e105722. PubMed ID: 25162631
[TBL] [Abstract][Full Text] [Related]
11. The 10 largest public and philanthropic funders of health research in the world: what they fund and how they distribute their funds.
Viergever RF; Hendriks TC
Health Res Policy Syst; 2016 Feb; 14():12. PubMed ID: 26892771
[TBL] [Abstract][Full Text] [Related]
12. UK investments in global infectious disease research 1997-2010: a case study.
Head MG; Fitchett JR; Cooke MK; Wurie FB; Hayward AC; Atun R
Lancet Infect Dis; 2013 Jan; 13(1):55-64. PubMed ID: 23140942
[TBL] [Abstract][Full Text] [Related]
13. Public funding for research on antibacterial resistance in the JPIAMR countries, the European Commission, and related European Union agencies: a systematic observational analysis.
Kelly R; Zoubiane G; Walsh D; Ward R; Goossens H
Lancet Infect Dis; 2016 Apr; 16(4):431-40. PubMed ID: 26708524
[TBL] [Abstract][Full Text] [Related]
14. Investments in sexually transmitted infection research, 1997-2013: a systematic analysis of funding awarded to UK institutions.
Head MG; Fitchett JR; Cassell JA; Atun R
J Glob Health; 2015 Dec; 5(2):020405. PubMed ID: 26322229
[TBL] [Abstract][Full Text] [Related]
15. Investments in respiratory infectious disease research 1997-2010: a systematic analysis of UK funding.
Head MG; Fitchett JR; Cooke MK; Wurie FB; Hayward AC; Lipman MC; Atun R
BMJ Open; 2014 Mar; 4(3):e004600. PubMed ID: 24670431
[TBL] [Abstract][Full Text] [Related]
16. Global Fund investments in human resources for health: innovation and missed opportunities for health systems strengthening.
Bowser D; Sparkes SP; Mitchell A; Bossert TJ; Bärnighausen T; Gedik G; Atun R
Health Policy Plan; 2014 Dec; 29(8):986-97. PubMed ID: 24197405
[TBL] [Abstract][Full Text] [Related]
17. Mapping pneumonia research: A systematic analysis of UK investments and published outputs 1997-2013.
Head MG; Fitchett JR; Newell ML; Scott JA; Harris JN; Clarke SC; Atun R
EBioMedicine; 2015 Sep; 2(9):1193-9. PubMed ID: 26501117
[TBL] [Abstract][Full Text] [Related]
18. Infectious disease research investments: systematic analysis of immunology and vaccine research funding in the UK.
Fitchett JR; Head MG; Atun R
Vaccine; 2013 Dec; 31(50):5930-3. PubMed ID: 24176489
[TBL] [Abstract][Full Text] [Related]
19. Systematic analysis of funding awarded for mycology research to institutions in the UK, 1997-2010.
Head MG; Fitchett JR; Atun R; May RC
BMJ Open; 2014 Jan; 4(1):e004129. PubMed ID: 24413353
[TBL] [Abstract][Full Text] [Related]
20. Domestic and donor financing for tuberculosis care and control in low-income and middle-income countries: an analysis of trends, 2002-11, and requirements to meet 2015 targets.
Floyd K; Fitzpatrick C; Pantoja A; Raviglione M
Lancet Glob Health; 2013 Aug; 1(2):e105-e115. PubMed ID: 25104145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
